Similarly, a glycopeptide-based PKM2 nano-activator has demonstrated efficacy in PC by promoting PKM2 tetramer formation and preventing dimeric nuclear translocation, ultimately impairing PC cell proliferation, chemoresistance, and metastatic potential (116). This evidence concerns the gene PKM and pachyonychia congenita.